Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213843) titled 'Combined Circulatory and Dietary Interventions for Neuropathy' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Loma Linda University
Condition:
Diabete Type 2
Neuropathy, Painful
Intervention:
Other: INF(R) Therapy
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2026
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07213843
Published by HT Digital Content ...